Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

07 Jun 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated June 7, 2022 titled ‘Zydus Lifesciences receives final approval from USFDA for Adapalene and Benzoyl Peroxide Topical Gel’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1914.70
Dr. Reddys Labs. 1386.00
Cipla 1413.40
Lupin 2018.15
Zydus Lifesciences 1227.50
View more..